Stock Market & Financial News
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell?
MRK trades near its 52-week high as Keytruda drives growth, while its pipeline and new products offer a path beyond the 2028 patent cliff.
MRK +2.26% AI Data Explosion: Can WDC Become a Bigger Storage Winner?
Western Digital is poised to benefit from AI-driven data growth as inference, Agentic AI and emerging workloads fuel long-term storage demand.
WDC +1.01% Tether is building a peer-to-peer search engine, and it already has a working demo
Tether's decentralized search engine could challenge tech giants, promoting privacy and reducing reliance on centralized data control. Tether is building a peer-to-peer search engine, and it already has a working demo.
Investors Are Buying Palantir for a Story That Is Not Quite True
Palantir's blowout growth numbers look like pure software success, but a closer look at how the company actually wins its deals reveals a business model that the current valuation may be dangerously misreading.
PLTR +5.17% 
4,011 XRP Wallets Drained in 3 Hours: 267,664 XRP Flows to Ethereum
XRPH Wallet was taken offline after 4,011 accounts were drained of 267,664 XRP and other tokens, exposing risks at the app layer, not XRPL itself.
Before You Chase Salesforce's Rally, Take a Closer Look at Its Latest Earnings Beat
Salesforce just posted an earnings beat that sent the stock surging 34%, but the source of that surprise raises questions every investor should answer before buying in at these levels.
CRM +0.58% 
Expert sets key XRP price level to watch
Crypto analyst Ali Martinez expects a potential 5% rally for XRP price if it breaks out of its descending triangle in the short time frame.
CAPL or GLP: Which Energy MLP Has the Stronger Investment Case?
CAPL and GLP bring distinct strengths in income, scale, leverage and valuation, setting up a closer comparison for energy MLP investors.
CAPL -0.83% 
New Strong Sell Stocks for September 8th
CRTO, DIN and LNWO have been added to the Zacks Rank #5 (Strong Sell) List on September 8, 2026.
CRTO +2.88% 
3 Dividend Growth Stocks to Buy as Fed Expected to Keep Rates Higher
Three dividend growth stocks are here to offer income and growth potential as interest rates may stay higher for longer.
CAKE +1.44% 
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
AMGN +1.82% 
S&P 500 Holds Firm as Investor Caution Builds
The Standard & Poor's 500 Index (SPX-7,718.60) May through July range has turned into an August-September consolidation, with roughly 200 SPX points separating the low and high ends of the ranges in both cases.
SPXC +0.52% 
Intel Climbs 5% on High-NA EUV Production Lead, ASML and Taiwan Semiconductor Advance 3%
A deepened High-NA EUV collaboration is lifting Intel (NASDAQ:INTC | INTC Price Prediction) and ASML Holding (NASDAQ:ASML) in Tuesday morning trading, with the semiconductor equipment story cutting against a softer market backdrop.
INTC -2.22% 
Buy 5 Top-Ranked Undervalued Stocks to Enhance Your Portfolio Returns
SMCI, ADM, ALL, CNC and AVT are five undervalued stocks with strong estimate revisions and growth prospects that could offer more upside in 2026.
ADM -3.1% 
Lilly Builds Neuroscience into a New Long-Term Growth Driver
Lilly is expanding its neuroscience pipeline through strong growth and M&A, aiming to build a new long-term driver beyond cardiometabolic therapies.
ATAI 0% 
Kinross Gold Stock Up 13% in a Month: What Should Investors Do Now?
KGC's 13% gain reflects stronger gold prices and earnings, but rising costs and falling estimates cloud its outlook.
KGC +1.71% 
Micron: My Target Was Hit, And One Question Is Still Open
Micron Technology, Inc. is downgraded from Buy to Hold after a 23% rally, as its valuation gap has closed. Key risk centers on the composition of $100B in long-term contracts—uncertainty remains whether these are heavily weighted to commoditized DRAM/NAND or high-margin HBM. Strong collateral ($22B in commitments) makes contract enforcement credible, but upside is capped and terminal value is less certain due to emerging Chinese competition.
TGT -0.72% 
Euro holds steady as US Dollar struggles for traction
Euro holds steady as US Dollar struggles for traction
Verizon Stock Is Near a 52-Week High. Here's Why I'm Still Bullish.
Verizon has quietly staged one of the year's most surprising large-cap comebacks, but the real question is whether the stock's best days are still ahead or already priced in.
VZ -8.75% 
Grounded and Falling: Why One Wall Street Pro Says Rocket Lab Will More Than Double Soon
Rocket Lab sits deep in the red after a rocket test failure spooked investors, yet one top Wall Street analyst just doubled down with a target that implies the stock more than doubles from here.
RKLB -0.28% 
Insmed: A Strong Launch And A Much Bigger Peak Sales Opportunity
Insmed is rated Strong Buy with a $175 target, offering ~39% upside from current levels. BRINSUPRI's rapid launch and raised peak sales guidance to $7B+ underpin INSM's commercial momentum and pipeline credibility. Management now estimates combined peak sales of $14B+ for its three lead drugs, up 75%, though some projections are not yet data-backed.
INSM +0.12% 
Buy Super Micro Computer for Handsome Returns & Attractive Valuations
SMCI's AI-driven growth, record backlog, liquid-cooling capabilities and attractive valuations support its buy appeal.
SMCI -2.13% 
4 Top-Performing Liquid Stocks to Enhance Portfolio Returns
ETSY, MNDY, SMTC and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.
ETSY +2.09% 
CPRI Gains as Michael Kors & Jimmy Choo Expand Consumer Reach
Capri Holdings expands consumer reach as Michael Kors and Jimmy Choo grow databases, generate major campaign impressions and lift client engagement.
CPRI +1.84% 
Can NEM Maintain Earnings Momentum Amid Production Challenges?
NEM faces production challenges as lower output and higher costs pressure 2026 goals.
NEM +1.98% 
Corcept: Not Cheap, But Backed By Real Structural Growth
Corcept Therapeutics is evolving into a multi-engine growth platform, driven by expanding Cushing's and a rapid oncology ramp with Lifyorli. CORT delivered strong 2Q26 results: $256.1M revenue (+32% YoY), $47.6M Lifyorli launch, and maintained profitability despite elevated launch expenses. CATALYST and MOMENTUM studies reveal Cushing's is more prevalent than previously thought, structurally expanding the addressable market and supporting multi-billion-dollar revenue potential.
CORT +2.24% 
Cathie Wood Targets $730K Bitcoin as BTC-Gold Ratio Climbs to 18
Cathie Wood says Bitcoin is breaking out against gold as the BTC-gold ratio reaches 18, even as BTC slips below $80,000 before the Fed.
Bonds Just Posted Their Worst Decade Since the Great Depression — Is This the Buying Opportunity of a Generation?
For years, bonds were treated as the portfolio ballast that investors could rely on when stocks stumbled. That assumption took a beating after 2020.
TLT +0.14% 
TNR Gold board urges rejection of Eucalyptus proxy bid ahead of shareholder vote
TNR Gold Corp (TSX-V:TNR, FRA:TNW, OTC:TRRXF) said it has filed and begun mailing a shareholder letter urging investors to vote only the BLUE proxy for the company's nominees ahead of a proxy contest with Eucalyptus Resources Opportunities Fund 1. The dissident group, led by Jon Christian Evensen and referred to by TNR as "Koala," is seeking to replace TNR's board.
TRRXF -7.41% 
CRO Rockets as Robinhood Takes Stakes in Crypto.com and OG.com
Robinhood has selected OG.com as an infrastructure and clearing partner for its prediction markets business.
